Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study
Authors
Craig H. Moskowitz (ORCID: https://orcid.org/0000-0002-9189-3152)
Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study
Craig H. Moskowitz, Erel Joffe, Efrat Luttwak, Jakub Svoboda et al.
Citations
2 citations
Journal
Blood
Topics
Lymphoma Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
0.85
article
Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study
Craig H. Moskowitz, Erel Joffe, Efrat Luttwak, Jakub Svoboda, Jaldhi Patel, Joachim Yahalom, Raphaël Steiner, Paul A. Hamlin, Kevin A. David, Ariela Noy, Anita J. Kumar, Heiko M. Schöder, Paola Ghione, W. Thomas Johnson, Gunjan L. Shah, Brandon S. Imber, Ahmet Doǧan, Tiffany Chang, Jennifer Kimberly Lue, Brittney Munayirji, Santosha A. Vardhana, Andrew M. Intlekofer, Alexandra Dreyfuss, Zachary Moore, Pallawi Torka, Beatrice Fregonese, Colette Owens, Alexander P. Boardman, Zachary D. Epstein‐Peterson, Andrew David Zelenetz, Alison J. Moskowitz, Michael J. LaRiviere, Steven M. Horwitz, Philip C. Caron, Theresa Davey, Alayna Santarosa, Gilles Salles, Robert N. Stuver, Alvaro Jose Alencar, John P. Plastaras, Derek Isrow, Lorenzo Falchi, Nivetha Ganesan, Maria Lia Palomba, Michael McNicholas
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BloodVol. 144(Supplement 1)
Institutions
Memorial Sloan Kettering Cancer Center (US), University of Miami (US), Kettering University (US), Sylvester Comprehensive Cancer Center (US), University of Pennsylvania (US)